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ABSTRACT  
Ibuprofen is a compound with low solubility but high permeability in water. One method to 
improve the ability of a substance to dissolve in water is through the formation of inclusion 
complexes. This study aims to obtain ratio between ibuprofen and -cyclodextrin which results in 
inclusion complex with an optimal amount of dissolved ibuprofen. The inclusion complex was 
made using solvent evaporation method with molar ratio variations of 1: 1, 1: 2, 1: 3, 1: 4 and 1: 
5. The results of the inclusion complex were characterized by X-ray diffraction, FTIR, SEM, and 
DTA. The solubility test was carried out using three different media; they are pH solution 7.4; pH 
solution 1.5; and distilled water. The solubility test results showed no increase on the ibuprofen 
solubility of the inclusion complex within medium solutions of pH 7.4 and pH 1.5 whereas in 
aquades medium there was an increase in the inclusion complex solubility compared to pure 
ibuprofen. Based on the results, it can be concluded that inclusion complex with molar ratio of 1: 
1 shows optimal amount of dissolved ibuprofen compared to other ratio variations in aquadest 
medium. 
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INTRODUCTION 
In a study conducted by Octavia et al. 
(2015), it was found that pure ibuprofen 
could not be dissolved for more than 70% in 
30 minutes. Such compound requires a 
method to increase its solubility to improve 
the bioavailability of drugs (Yasir et al. 
2010). Other studies investigating the 
increase of ibuprofen solubility have been 
carried out in the form of solid dispersion by 
the methods of solvent evaporation and 
melting dispersion (Gupta et al., 2011). This 
study uses relatively toxic organic solvents 
which will leave residue on the results of 
ibuprofen solid dispersion. 
Another way to improve the solubility 
of drugs that are difficult to dissolve in water 
is through the inclusion complex, through 
which can improve the speed of dissolution, 
absorption, bioavailability, and chemical 
stability of the drug (Loftsson & Brewster, 
1996). Inclusion complex is a form of 
inserting non-polar compounds (substrates) 
into a container of another compound 
(ligand) (Ketan et al., 2012). -cyclodextrin 
compound is one of cyclodextrin types that 
can be used as a ligand in the formation of 
inclusion complex. It is because -
cyclodextrin has relatively large cavity 
diameter of up to 6Å and good water 
solubility of 1 part in 20 parts of water 
(Rowe et al., 2012). 
Based on the explanation above, this 
research will produce an inclusion complex 
with a variation of ibuprofen:-cyclodextrin 
ratio using the solvent evaporation method 
due to an increase in ibuprofen solubility. 
The purpose of this study is to obtain ratio of 
ibuprofen:-cyclodextrin which produces 
inclusion complex with an optimal amount of 
dissolved ibuprofen.    
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METHODS 
The materials used in this study are 
ibuprofen (Hubei granules-biocause 
pharmaceutical), β-cyclodextrin (BaoJi 
GuoKang Bio-Technology), alcohol, 
aquadest, KCl (Merck), HCl (Merck), 
KH2PO4 (Merck), and NaOH (Merck). In 
addition, the instruments used in this study 
include X-ray diffractometer (Pan Analytical 
empryren), DTA (Mettler Toledo), UV-VIS 
spectrophotometer, SEM (SEM-eds JEOL 
JED350), FTIR spectrophotometer (Agilent), 
magnetic stirrer (Power MS-H-Pro), rotary 
evaporator (Butchi), and sieving (Retsch AS 
200 digits CA).  
 
Production of inclusion complex 
 The inclusion complex was made into 5 
formulas by varying the molar ratio between 
ibuprofen:-cyclodextrin which were 1: 1; 1: 
2; 1: 3; 1: 4 and 1: 5 (Table 1). Ibuprofen 
was dissolved in 50 ml of ethanol (M1) while 
β-cyclodextrin was dissolved in 50 ml of hot 
water (60°C) (M2). After that, the M2 clear 
solution was put into M1 clear solution and 
stirred using a magnetic stirrer at 300 rpm for 
30 minutes. The turbid solution is then 
evaporated (170 bar, 150 rpm, temperature 
40°C). The dried powder formed was sieved 
using a mesh of 100, then dried in a 
desiccator for 3 hours (Priotta, 2015).  
Characterization of inclusion complexes 
 Infrared spectra of ibuprofen, β-
cyclodextrin and inclusion complexes were 
recorded using FT-IR spectrophotometer by 
KBr pellet method. Measurements were 
made at wavenumbers 400 - 4000 cm-1 
(Hiremath et al, 2008). 
 DTA would characterize the solid-state 
interaction of the inclusion complex, -
cyclodextrin and, ibuprofen. The sample 
used was approximately 5 mg of ibuprofen, 
β-cyclodextrin, and inclusion complex at 
warming temperatures from 30 to 400 °C 
with a heating speed of 10 °C / minute (Ma 
et al., 2012). 
 XRD patterns of Ibuprofen, β-
cyclodextrins and inclusion complexes were 
recorded using X-ray diffractometer with Cu 
anode tube at 5-700 / 2θ intervals. The 
sample was placed on a plate-shaped holder 
made of aluminum. Diffractogram would be 
read automatically on the computer (Asih II, 
2011). 
 Particle morphology was observed 
using SEM. The powder sample (ibuprofen, 
β-cyclodextrin, inclusion complex) was 
placed in an aluminum sample holder and 
coated with gold with thickness of 10 nm. 
Samples were then observed for the 
enlargement of SEM devices. The voltage 
was set at 20 kV and the current was 12 mA 
(Octavia et al, 2015). 
 
Solubility test 
 A total of 100 mg of standard ibuprofen 
and inclusion complex results were dissolved 
into 20 ml of ethanol each, put into a 100 ml 
volumetric flask and dissolved with the 
medium (buffer pH 1.5/ distilled water) until 
the boundary mark. It was stirred using a 
magnetic stirrer at a speed of 150 rpm for 15 
minutes. A sample of 10 ml was taken and 
filtered with a 0.45 µm filtrate membrane. 
Absorption was measured at maximum 
wavelength using spectrophotometer. The 
solubility test was also carried out on solvent 
buffer pH 7.4 without the addition of ethanol 
to help to dissolve ibuprofen. 
 
DATA ANALYSIS 
 Solubility test data on dissolved 
ibuprofen levels were analyzed using non-
parametric analysis of Friedman because the 
data were not normally distributed and were 
not homogeneous.   
Tabel 1. Formula of Inclusion Complex 
 F 1 F 2 F 3 F 4 F 5 
β-cyclodextrine (g) 283,75 567,5  851,25  1135 1418,75 
Ibuprofen (g) 51,55 51,55 51,55 51,55 51,55 
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RESULTS AND DISCUSSION 
FTIR 
 The results of FTIR characterization from 
ibuprofen, β-cyclodextrin and inclusion 
complexes can be seen in Figure 1 and Table 
2. Inclusion complexes showed the presence 
of β-cyclodesktrin and ibuprofen groups. In 
formula 1 there were wavelengths of 1701.5 
cm-1 and 1459.3 cm-1 which were the peaks in 
ibuprofen, a slight shift in wavelength from 
1461 cm-1 to 1459 cm-1 (Barmi et al., 2018). 
In formula 2, a shift in wavelength from 
3283.8 to 3280.1 belonged to β-cyclodextrin 
(Silverstein et.al., 1981), but there was no 
aromatic peak of ibuprofen. The wavelength of 
ibuprofen aromatic group was not seen in 
formulas 3, 4 and 5 as well. Carboxylic group 
wavelength shift from 1701.5 to 1735.1 
belonged to ibuprofen in formula 3, formula 4 
and formula 5. This indicated a weak 
interaction between ibuprofen and β-
cyclodextrin (Hiremath et al., 2008). From 
these results, it was known that there was a 
shift in wavelength and appearance of 
ibuprofen, and wavelengths of -cyclodextrin 
which indicated an interaction between 
ibuprofen and -cyclodextrin  
. 
Tabel 2. Wave Number of FTIR 
 Distance wave number (cm-1) -cyclodextryn (cm-1) 
(O-H) 2500-3300 3263,3 
(C-H) aromatis  1000-1275 1099,6 
(C-O) alcohol dan fenol  1000-1300 1077,2 
 Distance wave number (cm-1) Ibuprofen (cm-1) 
(C=O) carboxylic acid  1701 1701.5 
(C=C) aromatic  1461 1460 
 Distance wave number (cm-1) Inclusion complex (cm-1)  
O-H 2500-3300 3265-3280,1 
C-H 1000-1275 1104.1 
C-O 1000-1300 1079.1 
C=O carboxylic acid 1701 1701.5-1735.1 
(C=C) aromatic  1461 1459 
Figure 1. IR Spectrum of ibuprofen, -cyclodextrin and inclusion complex.
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X-ray Diffractometry 
 It can be seen in Figure 2. In formula 1, 
the inclusion complex was formed due to the 
bonding of ibuprofen and -cyclodextrin so 
that the peaks in formula 1 and formula 2 were 
not too many. With the increase on the number 
of -cyclodextrin, the peaks were increasingly 
visible until formula 5, but did not cover the 
peak of ibuprofen. The diffraction pattern 
formed from formula 1 to formula 5 was 
increasingly seen approaching -cyclodextrin 
diffraction pattern with increasing peaks 
similar to -cyclodextrin. This signifies that 
ibuprofen molecule has entered the structure 
of -cyclodextrin cavity so that it looks 
dominant -cyclodextrin diffractogram (Rini 
et al., 2015). The decrease in height of peak 
intensity indicates a change in the structure so 
that the results of the inclusion complex are 
amorphous (Pamudji et al., 2014; Barmi et al., 
2018). 
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Figure 2. XRD result of ibuprofen, -cyclodextrin and inclusion complex. 
 
Differential Thermal Analysis  
 Formula 1 and formula 2 showed an 
endothermic process at a temperature of 
2900°C - 3200°C. Endothermic changes can 
occur due to oxidation of organic compounds 
(Setabudi et al., 2012). However, formula 3 
experienced an exothermic process at a 
temperature range of 2940°C - 3020°C and at 
that temperatures there was a change in mass. 
Meanwhile, in formula 4 and formula 5, 
exothermic process was directly followed by 
endothermic process. Exothermic process 
usually occurs due to the formation of crystals 
during the heating process which is often 
referred to solidification. 
In all results (Figure 3) on inclusion 
complex, dehydration which usually occurs at 
temperatures of around 1000°C is absent this 
time due to the disappearance of ibuprofen 
melting point. Ibuprofen loses its peak because 
it has entered the cavity of -cyclodextrin so 
that it does not show endothermic points at 
these adjacent temperatures (Hirameth 2008; 
Manca et al., 2005). 
 
Scanning Electron Microscope 
 The results of pure ibuprofen 
examination showed a long cylindrical rod 
shape while -cyclodextrin was seen as a lump 
with a rough and irregular texture. In the 
results of inclusion complex, all formulas 
appear to have no form that resembles 
ibuprofen and -cyclodextrin. In fact, almost 
all are irregular in shape (Figure 4). 
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(g) 
Figure 3. DTA result: (a) Formula 1, (b) Formula 2, (c) Formula 3, (d) Formula 4, (e) Formula 5, (f) ibuprofen, (g) -
cyclodextrin. 
   
Formula 1     Formula 2 
 
   
Formula 3     Formula 4 
 
Figure 4. SEM results 
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Formula 5     -cyclodextrin 
 
 
ibuprofen 
Figure 4. SEM results (Continued) 
 
Solubility Test  
 One of the most common methods in 
evaluation inclusion complexation is phase 
solubility. A phase solubility diagram is 
constructed by plotting the molar 
concentration of dissolved solute found on the 
vertical axis against the concentration of 
complexing agent added on the horizontal 
axis. Two general types of phase solubility 
profiles are generated; Type A where soluble 
complexes are formed, and Type B where 
complexes of limited solubility are formed 
(Higuchi & Connors, 1965).   
 The results (Figure 5) show that the 
addition of -cyclodextrin to the inclusion 
complex at solution of pH 7.4 and pH 1.5 
follows the type BI diagram which means that 
there is no increase in the solubility of 
ibuprofen with the addition of -cyclodextrin 
at ratios of 1: 1, 1: 2, 1: 3, 1: 4, and 1: 5. As 
with the aquadest medium, there is an increase 
in the solubility of ibuprofen in formula 1 
(ratio 1: 1) compared to pure ibuprofen, and 
the solubility type follows type Bs diagram.  
Curve Bs shows the formation of a complex 
that increases the total solubility of the 
compound (similar to type A diagram). More 
addition of complexing agents producing 
solubility of the complex is reached. As 
additional compound goes into solution, some 
solid complexes precipitate. Further addition 
of complexing agents beyond point z results in 
depletion of the compound from solution by 
complex formation. Curve BI is interpreted 
similarly except that the complex formed is so 
insoluble that no increase in solubility is 
observed (Mosher & Thompson, 2007). 
Statistical analysis of the solubility test results 
shows that sig ˂ 0.05 based on which it can be 
concluded that the 2 variables (ratio of 
ibuprofen:-cyclodextrin and the type of 
medium) generate different solubility results 
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Figure 5. Solubility phase diagram of inclusion complexes 
CONCLUSION 
The inclusion complex is not able to 
increase the solubility of ibuprofen within 
solution medium of pH 7.4 and pH 1.5. 
Meanwhile, in the aquadest medium, the 
formation of inclusion complexes can increase 
the solubility of ibuprofen at ratio of 1: 1. 
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